Fredun Pharmaceuticals share news, announcements and annual reports
NSE: FREDUNBSE: 539730Pharmaceuticals & BiotechnologySmall Cap
Fredun Pharmaceuticals Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Mar 2016
Last close ₹1,408.20up ₹41.20 (3.01%)BSE ₹1,408.80
Share price at the NSE close on 2 Nov 2026. Previous close ₹1,367.00.
2 Nov: open ₹1,360.00, high ₹1,420.00, low ₹1,350.10
52-week range of BSE trades to 2 Nov 2026
₹454.05Low, 12 Jan 2026₹1,666.35High, 8 Oct 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹2,380 Cr1,474th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 8.56
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.02%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 18.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.80
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 58,78644.2% delivered
Fredun Pharmaceuticals board meetings
187 filed, newest first. Page 1 of 4.
Oct 2026
23 Oct · Board meeting
Meeting on 23 Oct 20265 Oct · Board meeting
Sep 2026
22 Sep · Board meeting
16 Sep · Board meeting
Meeting on 16 Sep 2026
Jul 2026
30 Jul · Board meeting
Meeting on 5 Aug 2026: quarterly results
May 2026
15 May · Board meeting
Meeting on 25 May 2026: bonus issue, final dividend and audited results
Apr 2026
9 Apr · Board meeting
Meeting on 9 Apr 2026
Mar 2026
Jan 2026
30 Jan · Board meeting
Meeting on 9 Feb 2026: quarterly results
Oct 2025
28 Oct · Board meeting
Meeting on 8 Nov 2025: quarterly results
Sep 2025
22 Sep · Board meeting
Meeting on 25 Sep 2025: issue of warrants and preferential issue of shares
Jul 2025
14 Jul · Board meeting
Meeting on 30 Jul 2025: quarterly results
May 2025
31 May · Board meeting
22 May · Board meeting
Meeting on 30 May 2025: audited results and dividend
Jan 2025
22 Jan · Board meeting
Meeting on 4 Feb 2025: quarterly results
Oct 2024
26 Oct · Board meeting
15 Oct · Board meeting
Meeting on 26 Oct 2024: quarterly results
Sep 2024
26 Sep · Board meeting
Meeting on 3 Oct 2024
Jul 2024
29 Jul · Board meeting
22 Jul · Board meeting
Meeting on 29 Jul 2024: quarterly results
May 2024
10 May · Board meeting
7 May · Board meeting
Apr 2024
24 Apr · Board meeting
Meeting on 7 May 2024: audited results and final dividend15 Apr · Board meeting
Meeting on 15 Apr 2024
Mar 2024
22 Mar · Board meeting
Meeting on 22 Mar 2024: preferential issue of shares
Feb 2024